{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T03:33:48Z","timestamp":1790566428314,"version":"4.1.0"},"reference-count":166,"publisher":"Edizioni Minerva Medica","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Minerva Med"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.23736\/s0026-4806.20.07076-7","type":"journal-article","created":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T14:36:25Z","timestamp":1617892585000},"source":"Crossref","is-referenced-by-count":15,"title":["Cryoglobulinemic glomerulonephritis: clinical presentation and histological features, diagnostic pitfalls and controversies in the management. State of the art and the experience on a large monocentric cohort treated with B cell depletion therapy"],"prefix":"10.23736","volume":"112","author":[{"given":"Daniela","family":"ROSSI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savino","family":"SCIASCIA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"FENOGLIO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"FERRO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"BALDOVINO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joelle","family":"KAMGAING","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"VENTRELLA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ileana","family":"KALIKATZAROS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"VIZIELLO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"SOLFIETTI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"BARRECA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"ROCCATELLO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"17149","reference":[{"key":"10.23736\/S0026-4806.20.07076-7_ref001","doi-asserted-by":"publisher","DOI":"10.1016\/0022-1759(94)90284-4"},{"key":"10.23736\/S0026-4806.20.07076-7_ref002","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2012.671481"},{"key":"10.23736\/S0026-4806.20.07076-7_ref003","doi-asserted-by":"publisher","DOI":"10.1053\/sarh.2001.20265"},{"key":"10.23736\/S0026-4806.20.07076-7_ref004","first-page":"1473","article-title":"Hepatitis C virus infection in systemic lupus erythematosus: a case-control study","volume":"30","author":"Perlemuter G","year":"2003","journal-title":"J Rheumatol"},{"key":"10.23736\/S0026-4806.20.07076-7_ref005","first-page":"115","article-title":"Cryoglobulinaemias: a multi-centre study of the early clinical and laboratory manifestations of primary and secondary disease. GISC","volume":"88","author":"Monti G","year":"1995","journal-title":"QJM"},{"key":"10.23736\/S0026-4806.20.07076-7_ref006","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2796.2000.00627.x"},{"key":"10.23736\/S0026-4806.20.07076-7_ref007","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2007.02.019"},{"key":"10.23736\/S0026-4806.20.07076-7_ref008","doi-asserted-by":"publisher","DOI":"10.1007\/BF02828280"},{"key":"10.23736\/S0026-4806.20.07076-7_ref009","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/162.2.569"},{"key":"10.23736\/S0026-4806.20.07076-7_ref010","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)93443-D"},{"key":"10.23736\/S0026-4806.20.07076-7_ref011","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)92715-E"},{"key":"10.23736\/S0026-4806.20.07076-7_ref012","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-117-7-573"},{"key":"10.23736\/S0026-4806.20.07076-7_ref013","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(05)80123-0"},{"key":"10.23736\/S0026-4806.20.07076-7_ref014","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199211193272104"},{"key":"10.23736\/S0026-4806.20.07076-7_ref015","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.1997.475-ce1383.x"},{"key":"10.23736\/S0026-4806.20.07076-7_ref016","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(05)70216-4"},{"key":"10.23736\/S0026-4806.20.07076-7_ref017","doi-asserted-by":"publisher","DOI":"10.1086\/380202"},{"key":"10.23736\/S0026-4806.20.07076-7_ref018","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(66)90200-2"},{"key":"10.23736\/S0026-4806.20.07076-7_ref019","doi-asserted-by":"publisher","DOI":"10.1084\/jem.178.6.1903"},{"key":"10.23736\/S0026-4806.20.07076-7_ref020","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1002\/art.27490","article-title":"Detection of WA B cells in hepatitis C virus infection: a potential prognostic marker for cryoglobulinemic vasculitis and B cell malignancies","volume":"62","author":"Knight GB","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.23736\/S0026-4806.20.07076-7_ref021","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-3-25"},{"key":"10.23736\/S0026-4806.20.07076-7_ref022","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1995.78"},{"key":"10.23736\/S0026-4806.20.07076-7_ref023","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(80)90390-3"},{"key":"10.23736\/S0026-4806.20.07076-7_ref024","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.03710708"},{"key":"10.23736\/S0026-4806.20.07076-7_ref025","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1989.84"},{"key":"10.23736\/S0026-4806.20.07076-7_ref026","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2006.09.015"},{"key":"10.23736\/S0026-4806.20.07076-7_ref027","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-018-0009-4"},{"key":"10.23736\/S0026-4806.20.07076-7_ref028","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-127-10-199711150-00005"},{"key":"10.23736\/S0026-4806.20.07076-7_ref029","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-133-5-200009050-00025"},{"key":"10.23736\/S0026-4806.20.07076-7_ref030","doi-asserted-by":"publisher","DOI":"10.1046\/j.1469-0691.2003.00481.x"},{"key":"10.23736\/S0026-4806.20.07076-7_ref031","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-12-396028"},{"key":"10.23736\/S0026-4806.20.07076-7_ref032","doi-asserted-by":"publisher","DOI":"10.1126\/science.282.5390.938"},{"key":"10.23736\/S0026-4806.20.07076-7_ref033","first-page":"1138","article-title":"Replication of hepatitis C virus in B lymphocytes (CD19+)","volume":"94","author":"Morsica G","year":"1999","journal-title":"Blood"},{"key":"10.23736\/S0026-4806.20.07076-7_ref034","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2010.02.002"},{"key":"10.23736\/S0026-4806.20.07076-7_ref035","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1095"},{"key":"10.23736\/S0026-4806.20.07076-7_ref036","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.2204"},{"key":"10.23736\/S0026-4806.20.07076-7_ref037","doi-asserted-by":"crossref","unstructured":"Ferri C, Pileri S, Zignego AL. Hepatitis C virus, B-Cell disorders, and non-Hodgkin lymphoma. In: Goedert JJ, editor. Infectious Cause of Cancer. Target for Intervention. Totowa, NJ: Humana Press; 2000; p.349-68.","DOI":"10.1385\/1-59259-024-1:349"},{"key":"10.23736\/S0026-4806.20.07076-7_ref038","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)00078-7"},{"key":"10.23736\/S0026-4806.20.07076-7_ref039","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2008.02.011"},{"key":"10.23736\/S0026-4806.20.07076-7_ref040","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1993.161"},{"key":"10.23736\/S0026-4806.20.07076-7_ref041","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2011.249"},{"key":"10.23736\/S0026-4806.20.07076-7_ref042","first-page":"531","article-title":"Glomerulonephritis induced by human IgMK-IgG cryoglobulins in mice","volume":"69","author":"Fornasieri A","year":"1993","journal-title":"Lab Invest"},{"key":"10.23736\/S0026-4806.20.07076-7_ref043","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2008.07.027"},{"key":"10.23736\/S0026-4806.20.07076-7_ref044","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1984.00350190065012"},{"key":"10.23736\/S0026-4806.20.07076-7_ref045","first-page":"1","article-title":"Renal disease in essential mixed cryoglobulinaemia. Long-term follow-up of 44 patients","volume":"50","author":"Tarantino A","year":"1981","journal-title":"Q J Med"},{"key":"10.23736\/S0026-4806.20.07076-7_ref046","doi-asserted-by":"publisher","DOI":"10.1159\/000045243"},{"key":"10.23736\/S0026-4806.20.07076-7_ref047","doi-asserted-by":"publisher","DOI":"10.1159\/000190205"},{"key":"10.23736\/S0026-4806.20.07076-7_ref048","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1994.471"},{"key":"10.23736\/S0026-4806.20.07076-7_ref049","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1681\/ASN.V9122244","article-title":"Hepatitis C viral infection is associated with fibrillary glomerulonephritis and immunotactoid glomerulopathy","volume":"9","author":"Markowitz GS","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.23736\/S0026-4806.20.07076-7_ref050","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(87)90904-1"},{"key":"10.23736\/S0026-4806.20.07076-7_ref051","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2006.06.008"},{"key":"10.23736\/S0026-4806.20.07076-7_ref052","doi-asserted-by":"publisher","DOI":"10.1136\/gut.45.1.122"},{"key":"10.23736\/S0026-4806.20.07076-7_ref053","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(97)80281-4"},{"key":"10.23736\/S0026-4806.20.07076-7_ref054","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1746.1999.02015.x"},{"key":"10.23736\/S0026-4806.20.07076-7_ref055","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22759"},{"key":"10.23736\/S0026-4806.20.07076-7_ref056","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V81.5.1132.1132"},{"key":"10.23736\/S0026-4806.20.07076-7_ref057","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199403173301104"},{"key":"10.23736\/S0026-4806.20.07076-7_ref058","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V84.10.3336.3336"},{"key":"10.23736\/S0026-4806.20.07076-7_ref059","first-page":"81","article-title":"Treatment of mixed cryoglobulinemia with recombinant interferon alpha and adjuvant therapies. A prospective study on 20 patients","volume":"147","author":"Cohen P","year":"1996","journal-title":"Ann Med Interne (Paris)"},{"key":"10.23736\/S0026-4806.20.07076-7_ref060","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V90.10.3865"},{"key":"10.23736\/S0026-4806.20.07076-7_ref061","first-page":"343","article-title":"Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy","volume":"29","author":"Mazzaro C","year":"1997","journal-title":"Ital J Gastroenterol Hepatol"},{"key":"10.23736\/S0026-4806.20.07076-7_ref062","doi-asserted-by":"publisher","DOI":"10.1007\/BF01710739"},{"key":"10.23736\/S0026-4806.20.07076-7_ref063","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(93)90862-7"},{"key":"10.23736\/S0026-4806.20.07076-7_ref064","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199302183280703"},{"key":"10.23736\/S0026-4806.20.07076-7_ref065","first-page":"342","article-title":"Long-term effects of alpha-interferon therapy for type II mixed cryoglobulinemia","volume":"79","author":"Mazzaro C","year":"1994","journal-title":"Haematologica"},{"key":"10.23736\/S0026-4806.20.07076-7_ref066","first-page":"S181","article-title":"Effects of two different alpha-interferon regimens on clinical and virological findings in mixed cryoglobulinemia","volume":"13","author":"Mazzaro C","year":"1995","journal-title":"Clin Exp Rheumatol"},{"key":"10.23736\/S0026-4806.20.07076-7_ref067","first-page":"S175","article-title":"Interferon in the treatment of mixed cryoglobulinemia","volume":"13","author":"Migliaresi S","year":"1995","journal-title":"Clin Exp Rheumatol"},{"key":"10.23736\/S0026-4806.20.07076-7_ref068","doi-asserted-by":"publisher","DOI":"10.1007\/BF02990568"},{"key":"10.23736\/S0026-4806.20.07076-7_ref069","doi-asserted-by":"publisher","DOI":"10.1089\/jir.1996.16.585"},{"key":"10.23736\/S0026-4806.20.07076-7_ref070","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-199712000-00013"},{"key":"10.23736\/S0026-4806.20.07076-7_ref071","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-199711000-00008"},{"key":"10.23736\/S0026-4806.20.07076-7_ref072","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V92.8.2983"},{"key":"10.23736\/S0026-4806.20.07076-7_ref073","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00581.x"},{"key":"10.23736\/S0026-4806.20.07076-7_ref074","first-page":"2172","article-title":"Treatment of refractory, symptomatic, hepatitis C virus related mixed cryoglobulinemia with ribavirin and interferon-alpha","volume":"27","author":"Zuckerman E","year":"2000","journal-title":"J Rheumatol"},{"key":"10.23736\/S0026-4806.20.07076-7_ref075","doi-asserted-by":"publisher","DOI":"10.1002\/art.10699"},{"key":"10.23736\/S0026-4806.20.07076-7_ref076","first-page":"1775","article-title":"Interferon plus ribavirin in patients with hepatitis C virus positive mixed cryoglobulinemia resistant to interferon","volume":"30","author":"Mazzaro C","year":"2003","journal-title":"J Rheumatol"},{"key":"10.23736\/S0026-4806.20.07076-7_ref077","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2003.00022.x"},{"key":"10.23736\/S0026-4806.20.07076-7_ref078","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa013376"},{"key":"10.23736\/S0026-4806.20.07076-7_ref079","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403443"},{"key":"10.23736\/S0026-4806.20.07076-7_ref080","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.06.008"},{"key":"10.23736\/S0026-4806.20.07076-7_ref081","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-05-1711"},{"key":"10.23736\/S0026-4806.20.07076-7_ref082","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2004.10.031"},{"key":"10.23736\/S0026-4806.20.07076-7_ref083","doi-asserted-by":"publisher","DOI":"10.1002\/art.20958"},{"key":"10.23736\/S0026-4806.20.07076-7_ref084","first-page":"1164","article-title":"Persistent cryoglobulinemic vasculitis following successful treatment of hepatitis C virus","volume":"32","author":"Levine JW","year":"2005","journal-title":"J Rheumatol"},{"key":"10.23736\/S0026-4806.20.07076-7_ref085","doi-asserted-by":"publisher","DOI":"10.1002\/art.23305"},{"key":"10.23736\/S0026-4806.20.07076-7_ref086","first-page":"1641","article-title":"Exacerbation of peripheral neuropathy during alpha-interferon therapy in a patient with mixed cryoglobulinemia and hepatitis B virus infection","volume":"23","author":"La Civita L","year":"1996","journal-title":"J Rheumatol"},{"key":"10.23736\/S0026-4806.20.07076-7_ref087","first-page":"506","article-title":"Interferon toxicity in hepatitis C virus-associated type II cryoglobulinemia","volume":"16","author":"Di Lullo L","year":"1998","journal-title":"Clin Exp Rheumatol"},{"key":"10.23736\/S0026-4806.20.07076-7_ref088","first-page":"403","article-title":"[Cryoglobulinemia and hepatitis c: worsening of peripheral neuropathy after interferon alpha treatment]","volume":"23","author":"Lidove O","year":"1999","journal-title":"Gastroenterol Clin Biol"},{"key":"10.23736\/S0026-4806.20.07076-7_ref089","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/1529-0131(199905)42:5<1051::AID-ANR26>3.0.CO;2-Q","article-title":"Interferon-alpha may exacerbate cryoblobulinemia-related ischemic manifestations: an adverse effect potentially related to its anti-angiogenic activity","volume":"42","author":"Cid MC, Hern\u00e1ndez-Rodr\u00edguez J, Robert J, del R\u00edo A, Casademont J, Coll-Vinent B, et al","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.23736\/S0026-4806.20.07076-7_ref090","doi-asserted-by":"publisher","DOI":"10.1002\/mus.10118"},{"key":"10.23736\/S0026-4806.20.07076-7_ref091","doi-asserted-by":"publisher","DOI":"10.1097\/01.meg.0000108342.41221.0c"},{"key":"10.23736\/S0026-4806.20.07076-7_ref092","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1010494"},{"key":"10.23736\/S0026-4806.20.07076-7_ref093","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1056\/NEJMoa1012912","article-title":"Telaprevir for previously untreated chronic hepatitis C virus infection","volume":"364","author":"Jacobson IM","year":"2011","journal-title":"N Engl J Med"},{"key":"10.23736\/S0026-4806.20.07076-7_ref094","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1053\/j.gastro.2007.02.037","article-title":"Dynamic hepatitis C virus genotypic and phenotypic changes in patients treated with the protease inhibitor telaprevir","volume":"132","author":"Sarrazin C","year":"2007","journal-title":"Gastroenterology"},{"key":"10.23736\/S0026-4806.20.07076-7_ref095","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1002\/hep.23192","article-title":"Characterization of resistance to the protease inhibitor boceprevir in hepatitis C virus-infected patients","volume":"50","author":"Susser S","year":"2009","journal-title":"Hepatology"},{"key":"10.23736\/S0026-4806.20.07076-7_ref096","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jhep.2014.08.015","article-title":"PegIFN\u03b1\/ribavirin\/protease inhibitor combination in severe hepatitis C virus-associated mixed cryoglobulinemia vasculitis","volume":"62","author":"Saadoun D","year":"2015","journal-title":"J Hepatol"},{"key":"10.23736\/S0026-4806.20.07076-7_ref097","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jcv.2015.09.003","article-title":"Successful treatment of HCV-associated cryoglobulinemia with ombitasvir\/paritaprevir\/ritonavir, dasabuvir and ribavirin: A case report","volume":"72","author":"Makara M","year":"2015","journal-title":"J Clin Virol"},{"key":"10.23736\/S0026-4806.20.07076-7_ref098","doi-asserted-by":"crossref","first-page":"816424","DOI":"10.1155\/2015\/816424","article-title":"Combined treatment with antiviral therapy and rituximab in patients with mixed cryoglobulinemia: review of the literature and report of a case using direct antiviral agents-based antihepatitis C virus therapy","volume":"2015","author":"Urraro T","year":"2015","journal-title":"Case Reports Immunol"},{"key":"10.23736\/S0026-4806.20.07076-7_ref099","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2014.05.005"},{"key":"10.23736\/S0026-4806.20.07076-7_ref100","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2013.8700"},{"key":"10.23736\/S0026-4806.20.07076-7_ref101","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0232773"},{"key":"10.23736\/S0026-4806.20.07076-7_ref102","doi-asserted-by":"publisher","DOI":"10.7326\/M16-2575"},{"key":"10.23736\/S0026-4806.20.07076-7_ref103","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2013.06.014"},{"key":"10.23736\/S0026-4806.20.07076-7_ref104","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102589"},{"key":"10.23736\/S0026-4806.20.07076-7_ref105","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2017.03.006"},{"key":"10.23736\/S0026-4806.20.07076-7_ref106","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2018.05.021"},{"key":"10.23736\/S0026-4806.20.07076-7_ref107","doi-asserted-by":"publisher","DOI":"10.1016\/S1590-8658(00)80335-7"},{"key":"10.23736\/S0026-4806.20.07076-7_ref108","doi-asserted-by":"publisher","DOI":"10.1007\/BF01844200"},{"key":"10.23736\/S0026-4806.20.07076-7_ref109","doi-asserted-by":"publisher","DOI":"10.1159\/000236270"},{"key":"10.23736\/S0026-4806.20.07076-7_ref110","first-page":"221","article-title":"Intravenous methylprednisolone pulse therapy in essential mixed cryoglobulinemia nephropathy","volume":"19","author":"De Vecchi A","year":"1983","journal-title":"Clin Nephrol"},{"key":"10.23736\/S0026-4806.20.07076-7_ref111","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/BF02909366","article-title":"Chronic-relapsing polyneuropathy in the course of cryoglobulinemia. Clinical aspects and plasmapheretic treatment","volume":"16","author":"Caviglia AG","year":"1986","journal-title":"Ric Clin Lab"},{"key":"10.23736\/S0026-4806.20.07076-7_ref112","first-page":"187","article-title":"GISC protocol experience in the treatment of essential mixed cryoglobulinemia","volume":"13","author":"Pioltelli P","year":"1995","journal-title":"ClinExpRheumat"},{"key":"10.23736\/S0026-4806.20.07076-7_ref113","doi-asserted-by":"publisher","DOI":"10.1177\/039139889902200109"},{"key":"10.23736\/S0026-4806.20.07076-7_ref114","first-page":"101","article-title":"Type II essential mixed cryoglobulinaemia: presentation, treatment and outcome in 13 patients","volume":"82","author":"Frankel AH","year":"1992","journal-title":"Q J Med"},{"key":"10.23736\/S0026-4806.20.07076-7_ref115","first-page":"251","article-title":"Cryoglobulinaemia: clinical features and response to treatment","volume":"137","author":"Singer DR","year":"1986","journal-title":"Ann Med Interne (Paris)"},{"key":"10.23736\/S0026-4806.20.07076-7_ref116","first-page":"19","article-title":"Long term effects of cryoapheresis and cytostatic treatment in essential mixed cryoglobulinemia","volume":"8","author":"L'Abbate A","year":"1985","journal-title":"Int J Artif Organs"},{"key":"10.23736\/S0026-4806.20.07076-7_ref117","first-page":"15","article-title":"Plasma exchange in the treatment of essential mixed cryoglobulinemia nephropathy. Long-term follow up","volume":"8","author":"Sinico RA","year":"1985","journal-title":"Int J Artif Organs"},{"key":"10.23736\/S0026-4806.20.07076-7_ref118","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/BF02904753","article-title":"Plasma-exchange in the treatment of cryoglobulinemia","volume":"13","author":"Schena FP","year":"1983","journal-title":"Ric Clin Lab"},{"key":"10.23736\/S0026-4806.20.07076-7_ref119","doi-asserted-by":"publisher","DOI":"10.1080\/22953337.1982.11718870"},{"key":"10.23736\/S0026-4806.20.07076-7_ref120","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.1981.tb04625.x"},{"key":"10.23736\/S0026-4806.20.07076-7_ref121","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780240902"},{"key":"10.23736\/S0026-4806.20.07076-7_ref122","first-page":"114","article-title":"Immune material processing by phagocyte cell system in cryoglobulinemia","volume":"36","author":"Roccatello D","year":"1991","journal-title":"Clin Nephrol"},{"key":"10.23736\/S0026-4806.20.07076-7_ref123","first-page":"373","article-title":"Long-term plasma exchange. Analysis of indications, outcome and side effects","volume":"145","author":"Karmochkine M","year":"1994","journal-title":"Ann Med Interne (Paris)"},{"key":"10.23736\/S0026-4806.20.07076-7_ref124","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/BF02909369","article-title":"Plasma-exchange in mixed cryoglobulinemia. Effects on renal, liver and neurologic involvement","volume":"16","author":"Ferri C","year":"1986","journal-title":"Ric Clin Lab"},{"key":"10.23736\/S0026-4806.20.07076-7_ref125","doi-asserted-by":"publisher","DOI":"10.1159\/000183849"},{"key":"10.23736\/S0026-4806.20.07076-7_ref126","first-page":"47","article-title":"Prolonged plasma exchange in the treatment of renal involvement in essential mixed cryoglobulinemia","volume":"6","author":"Bombardieri S","year":"1983","journal-title":"Int J Artif Organs"},{"key":"10.23736\/S0026-4806.20.07076-7_ref127","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1979.tb01620.x"},{"key":"10.23736\/S0026-4806.20.07076-7_ref128","first-page":"68","article-title":"Trattamento con plasmaferesi ed IVIg nella sindrome crioglobulinemica grave resistente all'IFN-alfa","volume":"52","author":"Pietrogrande M","year":"2001","journal-title":"Reumatismo"},{"key":"10.23736\/S0026-4806.20.07076-7_ref129","doi-asserted-by":"publisher","DOI":"10.1002\/jca.20166"},{"key":"10.23736\/S0026-4806.20.07076-7_ref130","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00310-06"},{"key":"10.23736\/S0026-4806.20.07076-7_ref131","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-09-2856"},{"key":"10.23736\/S0026-4806.20.07076-7_ref132","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-10-3162"},{"key":"10.23736\/S0026-4806.20.07076-7_ref133","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfh469"},{"key":"10.23736\/S0026-4806.20.07076-7_ref134","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2007.06.008"},{"key":"10.23736\/S0026-4806.20.07076-7_ref135","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kel004"},{"key":"10.23736\/S0026-4806.20.07076-7_ref136","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-200605000-00018"},{"key":"10.23736\/S0026-4806.20.07076-7_ref137","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000183749.79424.b4"},{"key":"10.23736\/S0026-4806.20.07076-7_ref138","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-007-8019-0"},{"key":"10.23736\/S0026-4806.20.07076-7_ref139","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh080"},{"key":"10.23736\/S0026-4806.20.07076-7_ref140","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/41.10.1126"},{"key":"10.23736\/S0026-4806.20.07076-7_ref141","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.083584"},{"key":"10.23736\/S0026-4806.20.07076-7_ref142","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2006.06.131"},{"key":"10.23736\/S0026-4806.20.07076-7_ref143","doi-asserted-by":"publisher","DOI":"10.1016\/S1590-8658(07)80024-7"},{"key":"10.23736\/S0026-4806.20.07076-7_ref144","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2011.04.033"},{"key":"10.23736\/S0026-4806.20.07076-7_ref145","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-009-5072-z"},{"key":"10.23736\/S0026-4806.20.07076-7_ref146","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-11-253948"},{"key":"10.23736\/S0026-4806.20.07076-7_ref147","first-page":"84","article-title":"Efficacy of rituximab in severe and mild abdominal vasculitis in the course of mixed cryoglobulinemia","volume":"28","author":"Quartuccio L","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"10.23736\/S0026-4806.20.07076-7_ref148","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-10-245878"},{"key":"10.23736\/S0026-4806.20.07076-7_ref149","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2011.07.005"},{"key":"10.23736\/S0026-4806.20.07076-7_ref150","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-10-248518"},{"key":"10.23736\/S0026-4806.20.07076-7_ref151","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20318"},{"key":"10.23736\/S0026-4806.20.07076-7_ref152","first-page":"93","article-title":"A randomized, controlled, multicenter phase III study of the efficacy and safety of rituximab (RTX) monotherapy versus the best available treatment (BAT) in patients with mixed cryoglobulinemia syndrome (MC)","volume":"69","author":"De Vita S","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.23736\/S0026-4806.20.07076-7_ref153","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.084939"},{"key":"10.23736\/S0026-4806.20.07076-7_ref154","doi-asserted-by":"publisher","DOI":"10.1016\/S1590-8658(07)80023-5"},{"key":"10.23736\/S0026-4806.20.07076-7_ref155","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh470"},{"key":"10.23736\/S0026-4806.20.07076-7_ref156","doi-asserted-by":"publisher","DOI":"10.1002\/art.25000"},{"key":"10.23736\/S0026-4806.20.07076-7_ref157","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.16986"},{"key":"10.23736\/S0026-4806.20.07076-7_ref158","doi-asserted-by":"publisher","DOI":"10.1016\/S1590-8658(07)80025-9"},{"key":"10.23736\/S0026-4806.20.07076-7_ref159","first-page":"22","article-title":"Prophylaxis and therapy of HBV infection in 20 patients treated with disease modifying antirheumatic drugs or with biological agents for rheumatic diseases","volume":"60","author":"Zingarelli S","year":"2008","journal-title":"Reumatismo"},{"key":"10.23736\/S0026-4806.20.07076-7_ref160","doi-asserted-by":"publisher","DOI":"10.1136\/ard.61.10.922"},{"key":"10.23736\/S0026-4806.20.07076-7_ref161","doi-asserted-by":"publisher","DOI":"10.1002\/art.24703"},{"key":"10.23736\/S0026-4806.20.07076-7_ref162","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2003.12.057"},{"key":"10.23736\/S0026-4806.20.07076-7_ref163","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfh564"},{"key":"10.23736\/S0026-4806.20.07076-7_ref164","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-11-122713"},{"key":"10.23736\/S0026-4806.20.07076-7_ref165","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2008.05.005"},{"key":"10.23736\/S0026-4806.20.07076-7_ref166","unstructured":"Fervenza FC, Leise MD, Roccatello D, Kyle RA. Mixed cryoglobulinemia syndrome: Treatment and prognosis. UpToDate; [Internet]. Available from: https:\/\/www.uptodate.com\/contents\/mixed-cryoglobulinemia-syndrome-treatment-and-prognosis?topicRef=3062&amp;source=see_link [cited 2020, Nov 11]."}],"container-title":["Minerva Medica"],"original-title":[],"link":[{"URL":"https:\/\/www.minervamedica.it\/pdf.php?cod=R10Y2021N02A0162","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T21:05:46Z","timestamp":1698872746000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.minervamedica.it\/index2.php?show=R10Y2021N02A0162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":166,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.23736\/s0026-4806.20.07076-7","relation":{},"ISSN":["0026-4806","1827-1669"],"issn-type":[{"value":"0026-4806","type":"print"},{"value":"1827-1669","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4]]}}}